SecBot SecBot
8-K ·Filed Oct 22, 2026

LUCD

Lucid Diagnostics Inc.
BEARISH
Impact 6/10
Horizonweeks Processed4d 11h ago SEC0001493152-26-048114
8-K context-dependent: Items 3.02, 3.03
Actionable Insight ▼ Bearish

Massive potential dilution from the $0.3519 conversion price and 20% PIK dividend creates a strong downward overhang on LUCD common stock. Monitor for early conversion activity and the filing of the resale registration statement, which could accelerate selling pressure. The reset of the existing notes' conversion price to the same level compounds the dilution risk.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+1d
LUCD ▲ +21.82% at T+1d
SHORT call ✗ call lost -21.82% · α vs SPY -21.11% · entry $0.4110 → $0.5007
Next anchor: T+5d in 2d
Entry = T+0 close
Oct 22, 2026
via day close
T+1d
+21.82%
call -21.82% · α -21.11%
$0.5007
settled 4d ago
T+5d
Pending
in 2d
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Lucid Diagnostics raised $15.0 million via a private placement of 15,000 shares of newly created Series C Convertible Preferred Stock at $1,000 per share. The preferred stock carries a 20% annual dividend payable in common stock, converts at $0.3519 per share, and includes a 4.99% beneficial ownership cap and a 19.99% Nasdaq primary market limitation. The conversion price also triggers a reduction in the conversion price of the company's existing 12.0% senior secured convertible notes due 2029 to the same $0.3519 level, and the company has agreed to file a resale registration statement for the underlying common shares.

Key Financial Metrics

Offering Size
$15.0M

Key Facts

  • Gross proceeds of $15.0 million from sale of 15,000 Series C Convertible Preferred shares at $1,000 per share.
  • Conversion price set at $0.3519 per share, equal to Nasdaq's Minimum Price under Listing Rule 5635(d).
  • 20% annual dividend payable quarterly in common stock (PIK shares), with potential stated value increases if market value of PIK shares falls below conversion price.
  • Mandatory conversion triggers: fundamental transaction, VWAP ≥ $5.00 for 20 of 30 trading days after 24 months, or VWAP ≥ conversion price after March 31, 2030.
  • Beneficial ownership limitation of 4.99% and Nasdaq primary market limitation of 19.99% of pre-offering outstanding common stock.
  • Issuance reduces conversion price of existing 12.0% Senior Secured Convertible Notes due 2029 to $0.3519.
  • Company must reserve at least 60 million common shares for conversion and dividends.
  • Registration rights agreement requires filing of resale registration statement within 120 days of initial closing.
  • Holders of a majority of Series C Preferred have right to designate one board director while 25% of original shares remain outstanding.

Financial Impact

$15.0 million gross proceeds from Series C Preferred offering; potential dilution of up to 42.6 million common shares at $0.3519 conversion price (based on $15M stated value), plus ongoing 20% annual PIK dividend in common stock; existing note conversion price reset to $0.3519 may trigger further dilution.

dilutiondebtshare countcapital structure

Risk Factors

  • Extreme dilution: full conversion of Series C Preferred at $0.3519 would add ~42.6M shares, dwarfing current float.
  • 20% annual PIK dividend continuously increases share count and stated value, compounding dilution.
  • Existing note conversion price reset to $0.3519 may trigger additional conversion and dilution.
  • Low conversion price relative to any potential stock price recovery creates persistent overhang.
  • Nasdaq 19.99% primary market limitation may delay conversions but does not eliminate eventual dilution.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-048114
Exhibit: ex10-1.htm0001493152-26-048114
Document: form8-k.htm0001493152-26-048114
Document: 0001493152-26-048114-index-headers.html0001493152-26-048114
Document: 0001493152-26-048114-index.html0001493152-26-048114
Document: 0001493152-26-048114.txt0001493152-26-048114
7 reports for LUCD
Performance horizon
67% Hit rate @ T+1 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+1▲ +6.63%Oct 16, 2026
Filters
Rows
Reports for LUCD — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
BEARISH ★ 6/10
$0.4110 $0.5007▼ −21.82%▼ −21.11%$0.5010 (−21.90%)
Oct 16, 2026
10d ago
8-K
BEARISH ★ 7/10
$0.3770 $0.3520▲ +6.63%▲ +6.97%$0.5010 (−32.89%)
Sep 22, 2026
4w ago
8-K
BULLISH ★ 5/10
$0.8930 $0.8390▼ −6.05%▼ −5.33%$0.5010 (−43.90%)
Aug 13, 2026
10w ago
8-K
MIXED ★ 5/10
$0.9649 $0.9677▲ +0.29%▲ +0.49%$0.5010 (−48.08%)
May 14, 2026
23w ago
8-K
BEARISH ★ 5/10
$1.02 $0.9910▲ +2.84%▲ +1.62%$0.5010 (+50.88%)
Apr 24, 2026
26w ago
8-K
NEUTRAL ★ 5/10
$1.06 $1.04▼ −1.89%▼ −1.40%$0.5010 (−52.74%)
Apr 23, 2026
26w ago
8-K
NEUTRAL ★ 5/10
$1.07 $1.06▼ −0.93%▼ −1.10%$0.5010 (−53.18%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 5h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 22, 2026